Back to mobile site

More on BIOD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.5 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BIOD Cash Flow Statement

Click line-items for a historical chart and %
Net loss
Depreciation and amortization 81K
Founder's compensation contributed to capital
Share-based compensation for employees and directors 581K
Share-based compensation for non-employees
Loss on settlement of debt
Write-off of loan to related party
Write-off of capitalized patent expense
Adjustment to fair value of common stock warrant liability 2K
Taxes receivable
Other receivables
Prepaid expenses and other assets -21K
Accounts payable 46K
Income taxes payable 0
Accrued expenses and long term liabilities 1.49M
Total adjustments 1.97M
Net cash used in operating activities -10.2M
Purchase of property and equipment 404K
Purchase of marketable securities
Sale of marketable securities
Acquisition of intellectual property
Loan to related party
Net cash (used in) provided by investing activities 404K
Cash flows from financing activities:
Restricted cash -21K
Options exercised
Warrants exercised
Employee stock purchase plan 0
Deferred public offering costs
Stockholder contribution
Net proceeds from sale of Series A preferred stock 2011
Net proceeds from sale of common stock
Proceeds from bridge financing
Net cash provided by financing activities -21K
Net (decrease) increase in cash and cash equivalents -9.82M
Cash and cash equivalents, beginning of period 40.85M
Cash and cash equivalents, end of period 31.02M
Interest
Income taxes 19K
Warrants issued in connection with registered direct financing
Settlement of debt with Series B preferred stock
Accrued expenses settled with Series B preferred stock
Deemed dividend - warrants
Accretion of fair value of beneficial charge on preferred stock
Conversion of convertible preferred stock to common stock
Cash flows from financing activities:
Net proceeds from sale of preferred stock
Cash flows from financing activities:
Net proceeds from sale of preferred stock

Entities mentioned with BIOD

View All Entities